<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Cold Spring Harb Perspect Med</journal-id>
<journal-id journal-id-type="iso-abbrev">Cold Spring Harb Perspect Med</journal-id>
<journal-id journal-id-type="publisher-id">cshperspectmed</journal-id>
<journal-id journal-id-type="hwp">cshperspectmed</journal-id>
<journal-title-group>
<journal-title>Cold Spring Harbor Perspectives in Medicine</journal-title>
</journal-title-group>
<issn pub-type="epub">2157-1422</issn>
<publisher>
<publisher-name>Cold Spring Harbor Laboratory Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26637437</article-id>
<article-id pub-id-type="pmc">4691802</article-id>
<article-id pub-id-type="doi">10.1101/cshperspect.a022707</article-id>
<article-id pub-id-type="publisher-id">a022707</article-id>
<article-categories>
<subj-group subj-group-type="hwp-journal-coll">
<subject>105</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Perspectives</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Neonatal and Infantile Epilepsy: Acquired and Genetic Models</article-title>
<alt-title alt-title-type="left-running">A.S. Galanopoulou and S.L. Moshé</alt-title>
<alt-title alt-title-type="right-running">Animal Models of Early-Life Epilepsy</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Galanopoulou</surname>
<given-names>Aristea S.</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Moshé</surname>
<given-names>Solomon L.</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="aff" rid="af2">2</xref>
</contrib>
</contrib-group>
<aff id="af1"><label>1</label>Saul R. Korey Department of Neurology, Dominick P. Purpura Department of Neuroscience, Laboratory of Developmental Epilepsy, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York 10461</aff>
<aff id="af2"><label>2</label>Department of Pediatrics, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York 10461</aff>
<author-notes>
<corresp><italic>Correspondence:</italic><email>aristea.galanopoulou@einstein.yu.edu</email>; <email>solomon.moshe@einstein.yu.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>1</month>
<year>2016</year>
</pub-date>
<volume>6</volume>
<issue>1</issue>
<elocation-id>a022707</elocation-id>
<permissions>
<copyright-statement>Copyright © 2016 Cold Spring Harbor Laboratory Press; all rights reserved</copyright-statement>
<copyright-year>2016</copyright-year>
</permissions>
<self-uri content-type="pdf" xlink:href="cshperspectmed-BEP-a022707.pdf" xlink:type="simple"></self-uri>
<abstract>
<p>The incidence of seizures and epilepsies is particularly high during the neonatal and infantile periods. We will review selected animal models of early-life epileptic encephalopathies that have addressed the dyscognitive features of frequent interictal spikes, the pathogenesis and treatments of infantile spasms (IS) or Dravet syndrome, disorders with mammalian target of rapamycin (mTOR) dysregulation, and selected early-life epilepsies with genetic defects. Potentially pathogenic mechanisms in these conditions include interneuronopathies in IS or Dravet syndrome and mTOR dysregulation in brain malformations, tuberous sclerosis, and related genetic disorders, or IS of acquired etiology. These models start to generate the first therapeutic drugs, which have been specifically developed in immature animals. However, there are challenges in translating preclinical discoveries into clinically relevant findings. The advances made so far hold promise that the new insights may potentially have curative or disease-modifying potential for many of these devastating conditions.</p>
</abstract>
<abstract abstract-type="precis">
<p>Compared to other stages of life, the incidence of epileptic seizures in infants is particularly high. Animal models that recapitulate early-life epilepsies have improved our understanding and ability to treat them.</p>
</abstract>
<counts>
<page-count count="24"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>